Givaudan | GIVN - Sales Revenues


Givaudan reported CHF3.61B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Air Liquide EUR 6.79B 6.43B Mar/2026
Akzo Nobel EUR 2.39B 20M Mar/2026
Anheuser-Busch USD 15.27B 290M Mar/2026
Arkema EUR 2.18B 70M Mar/2026
Associated British Foods GBP 9.46B 490M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Beiersdorf EUR 2.48B 170M Mar/2026
British American Tobacco GBP 13.5B 1.43B Dec/2025
Covestro EUR 2.92B 255M Dec/2025
Croda International GBP 825.73M 412.23M Dec/2025
Danone EUR 6.71B 170M Dec/2025
Diageo GBP 5.59B 3.76B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Givaudan CHF 3.61B 256M Dec/2025
Heineken EUR 14.57B 392M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
International Flavors Fragrances USD 2.74B 150M Mar/2026
Johnson Matthey GBP 1.28B 0 Mar/2026
Kerry EUR 3.88B 0 Dec/2024
Lonza CHF 3.58B 63M Jun/2025
L'Oréal EUR 21.58B 10.84B Dec/2025
Merck EUR 5.13B 120M Mar/2026
Nestle CHF 45.26B 1.03B Dec/2025
Pernod Ricard EUR 1.94B 3.31B Mar/2026
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
SGS CHF 3.46B 1.79B Dec/2024
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 997M 2M Mar/2026
Tate & Lyle GBP 983.99M 40.01M Mar/2026
Umicore EUR 10.68B 8.89B Dec/2025
Victrex GBP 147.1M 71.6M Mar/2026